Prenatal prediction of neonatal growth status in twins using individualized growth assessment
- PMID: 8621807
- DOI: 10.1002/(SICI)1097-0096(199602)24:2<53::AID-JCU1>3.0.CO;2-J
Prenatal prediction of neonatal growth status in twins using individualized growth assessment
Abstract
Objective: To determine if the growth status at birth of twins can be predicted in the third trimester using the Prenatal Growth Assessment Score (PGAS).
Methods: The growth of 40 twin fetuses were studied with ultrasound from 14 weeks until delivery. Measurements of the head circumference (HC), abdominal circumference (AC), thigh circumference (ThC), femur diaphysis length (FDL), head cube (A), and abdominal cube (B) were made at 2 to 3 week intervals. Rossavik growth models for these parameters were determined from second trimester measurements. These models were used to define expected third trimester growth curves and birth characteristics. Comparisons of expected and actual third trimester measurements were used to calculate PGAS values after various time points (PGASAt) and after the last time point (PGASAT). Similar comparisons after birth were used to determine Growth Potential Realization Index (GPRI) values for HC, AC, ThC, weight (WT), and crown-heel length (CHL), with and without correction for decreased soft tissue deposition. These two sets of GPRI values were used to calculate two sets of Neonatal Growth Assessment Scores (NGASS, NGASTw). Using NGASS and NGASTw (as well as GPRI values in some cases), the twin neonates were classified as Normal (N), Decreased Soft Tissue Deposition, (DSTD), Intrauterine Growth Retardation (IUGR) and Macrosomia (M).
Results: At birth 22/40 (55%) were classified as N, 9/40 (22.5%) as DSTD, 6/40 (15.0%) as IUGR, and 3/40 (7.5%) as M. All -PGASAT values in the N group were greater than -0.40% with one exception (-PGASAT = -0.43%). All PGASAt values were above this same boundary except for one fetus. No differences were seen between the N and DSTD groups [mean -PGASAT (range): N, -0.12% (0% to -0.34%); DSTD, -0.10% (0% to -0.30%)]. The IUGR group had 4 fetuses with -PGASAT values between -0.65% and 2.79% and two with values of 0.0% and -0.12%. Growth retardation in the latter two was limited to a decrease in thigh soft tissue deposition. -PGASAt values in the first 4 fetuses were below -0.40% 1.6 to 9.5 weeks before delivery (mean: 6.1 weeks). Fetuses in group M had +PGASAT values of 0.0%, +1.8%, and +1.2%. PGASAt values were above +0.40% at 3.6 and 9.8 weeks before delivery in the latter two fetuses.
Conclusions: These results support the concept that PGASAT and PGASAt values outside +/- 0.40% indicate either IUGR or macrosomia. Almost all fetuses with growth problems in the third trimester can be detected, on average, 6 weeks before delivery unless the growth abnormality is limited to decreased soft tissue deposition.
Similar articles
-
Identification of Macrosomic, normal and intrauterine growth retarded neonates using the modified Neonatal Growth Assessment Score.Fetal Diagn Ther. 2004 Jan-Feb;19(1):58-67. doi: 10.1159/000074262. Fetal Diagn Ther. 2004. PMID: 14646420
-
Evaluation of twin growth status at birth using individualized growth assessment: comparison with conventional methods.J Clin Ultrasound. 1995 Jun;23(5):277-86. doi: 10.1002/jcu.1870230502. J Clin Ultrasound. 1995. PMID: 7642765
-
Individual growth curve standards in triplets: prediction of third-trimester growth and birth characteristics.Obstet Gynecol. 1991 Sep;78(3 Pt 1):379-84. Obstet Gynecol. 1991. PMID: 1876369
-
Sonographic examination does not predict twin growth discordance accurately.Obstet Gynecol. 1997 Apr;89(4):529-33. doi: 10.1016/S0029-7844(97)00010-0. Obstet Gynecol. 1997. PMID: 9083307 Review.
-
Fetal growth in multifetal gestation.Clin Obstet Gynecol. 1997 Dec;40(4):764-70. doi: 10.1097/00003081-199712000-00011. Clin Obstet Gynecol. 1997. PMID: 9429791 Review.
Cited by
-
Fetal growth pathology score: a novel ultrasound parameter for individualized assessment of third trimester growth abnormalities.J Matern Fetal Neonatal Med. 2018 Apr;31(7):866-876. doi: 10.1080/14767058.2017.1300646. Epub 2017 Mar 20. J Matern Fetal Neonatal Med. 2018. PMID: 28277911 Free PMC article.
-
A modified prenatal growth assessment score for the evaluation of fetal growth in the third trimester using single and composite biometric parameters.J Matern Fetal Neonatal Med. 2015 May;28(7):745-54. doi: 10.3109/14767058.2014.934218. Epub 2014 Jul 11. J Matern Fetal Neonatal Med. 2015. PMID: 24993892 Free PMC article.
-
Fractional fetal thigh volume in the prediction of normal and abnormal fetal growth during the third trimester of pregnancy.Am J Obstet Gynecol. 2017 Oct;217(4):453.e1-453.e12. doi: 10.1016/j.ajog.2017.06.018. Epub 2017 Jun 23. Am J Obstet Gynecol. 2017. PMID: 28651860 Free PMC article.
-
Third trimester growth restriction patterns: individualized assessment using a fetal growth pathology score.J Matern Fetal Neonatal Med. 2018 Aug;31(16):2155-2163. doi: 10.1080/14767058.2017.1337741. Epub 2017 Jul 6. J Matern Fetal Neonatal Med. 2018. PMID: 28573931 Free PMC article.
-
Individualized growth assessment: conceptual framework and practical implementation for the evaluation of fetal growth and neonatal growth outcome.Am J Obstet Gynecol. 2018 Feb;218(2S):S656-S678. doi: 10.1016/j.ajog.2017.12.210. Am J Obstet Gynecol. 2018. PMID: 29422206 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical